COMP <GO>
CNMD vs AXGN // EV/EBITDA & P/E VALUATION
CONMED Corporation (NYSE) VS. Axogen Inc. (NASDAQ) • 15-METRIC TALLY: CNMD 6
— AXGN 6
■ METRIC PARITY
LAST: $44.29 (-3.13%) • MKT CAP: $1.36B
valuation
11.4x
LAST: $49.37 (-0.52%) • MKT CAP: $2.96B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CNMD VS. AXGN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CNMD | AXGN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 54.60% | 74.30% | -19.70 | AXGN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.80% | -2.60% | +10.40 | CNMD | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 11.4x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 11.07% | -0.10% | +11.17 | CNMD | /fcf-yield <GO> |
| Operating Margin | 7.50% | -3.50% | +11.00 | CNMD | /operating-margins <GO> |
| Net Profit Margin | 3.40% | -7.00% | +10.40 | CNMD | /net-margins <GO> |
| Revenue Growth (YoY) | 5.20% | 20.20% | -15.00 | AXGN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.82% | 0.00% | +1.82 | CNMD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.91 | 18.64 | -16.73 | AXGN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | CNMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.1 | 74.3 | -27.20 | AXGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.10 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.9x | 18.0x | +8.90 | AXGN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.36B | $2.96B | -$1.60B | AXGN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CNMD REV | AXGN REV | CNMD GROSS % | AXGN GROSS % | CNMD FCF | AXGN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.37B | $225.2M | 54.6% | 74.3% | $150.9M | -$2.9M |
| FY 2024 | $1.31B | $187.3M | 56.1% | 75.8% | $153.9M | $1.4M |
| FY 2023 | $1.24B | $159.0M | — | — | $125.3M | -$12.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CNMD // BETA —
AXGN // BETA 1.10